Nova Patents
AT332965T

Complementing cell lines

Abstract

A packaging cell line capable of complementing recombinant adenovirus based on a serotype from subgroup B, wherein said cell line derived from a human cell that has been transformed by the coding sequences of E1 of an adenovirus wherein the sequence encoding the protein E1B-55K it is subgroup B.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

81 members in 24 offices

This recordMember, by publication datePriority claim14 more offices are in the list below

Priority claims1

Priority claims
DocumentOfficeKindDate
71367800United States of AmericaA

Members81

Family members, oldest first
DocumentOfficeKind
CA2428739A1CanadaA1
WO0240665A2World Intellectual Property Organization (WIPO)A2
AU1856902AAustraliaA
WO0240665A3World Intellectual Property Organization (WIPO)A3
US6492169B1United States of AmericaB1
US2003119192A1United States of AmericaA1
US2003171336A1United States of AmericaA1
US2003185801A1United States of AmericaA1
EP1349926A2European Patent Office (EPO)A2
CA2477954A1CanadaA1
WO03104467A1World Intellectual Property Organization (WIPO)A1
AU2003271737A1AustraliaA1
JP2004513657AJapanA
MXPA04008891AMexicoA
KR20040106363ARepublic of KoreaA
BR0308783ABrazilA
NO20045130LNorwayL
EP1497438A1European Patent Office (EPO)A1
US6869794B2United States of AmericaB2
US2005084480A1United States of AmericaA1
EA200401424A1Eurasian Patent Organization (EAPO)A1
HK1068371AHong Kong, ChinaA
HK1068371A1Hong Kong, ChinaA1
US6913922B1United States of AmericaB1
US2005158278A1United States of AmericaA1
CN1650020AChinaA
JP2005523729AJapanA
PL373304A1PolandA1
US2005232900A1United States of AmericaA1
NZ525997ANew ZealandA
ZA200406942BSouth AfricaB
US6974695B2United States of AmericaB2
US2005277194A1United States of AmericaA1
IL164803A0IsraelA0
IL164803D0IsraelD0
EP1349926B1European Patent Office (EPO)B1
AT332965TThis recordAustriaT
ATE332965T1AustriaT1
DE60121471D1GermanyD1
DK1349926T3DenmarkT3
PT1349926EPortugalE
SI1349926T1SloveniaT1
DE60121471T2GermanyT2
US2007041946A1United States of AmericaA1
ES2267864T3SpainT3
AU2002218569B2AustraliaB2
AU2003271737B2AustraliaB2
NZ534866ANew ZealandA
US7250293B2United States of AmericaB2
US7270811B2United States of AmericaB2
US7344883B2United States of AmericaB2
US2008171018A1United States of AmericaA1
US2008199433A1United States of AmericaA1
US2008199917A1United States of AmericaA1
US7468181B2United States of AmericaB2
EA010828B1Eurasian Patent Organization (EAPO)B1
CN100497639CChinaC
EP1497438B1European Patent Office (EPO)B1
AT447037TAustriaT
ATE447037T1AustriaT1
DE60329835D1GermanyD1
DK1497438T3DenmarkT3
JP4402881B2JapanB2
PT1497438EPortugalE
US2010034774A1United States of AmericaA1
CY1105232T1CyprusT1
ES2335657T3SpainT3
SI1497438T1SloveniaT1
JP4495587B2JapanB2
US7820440B2United States of AmericaB2
CA2428739CCanadaC
KR101021387B1Republic of KoreaB1
US7906113B2United States of AmericaB2
IL164803AIsraelA
NO332108B1NorwayB1
CA2477954CCanadaC
US8221971B2United States of AmericaB2
US2013156736A1United States of AmericaA1
PL215165B1PolandB1
US2015010952A1United States of AmericaA1
US9228205B2United States of AmericaB2